Effectively Using EBITDA Multiples for Pharma Company Valuation

Leveraging EBITDA Multiples for Accurate Pharma Company Valuations Determining the valuation of pharmaceutical and biotechnology companies is a crucial exercise to inform high-impact decisions including organic investments and prioritization, licensing…

Continue ReadingEffectively Using EBITDA Multiples for Pharma Company Valuation

Sales force competitive intelligence in the pharmaceutical and medical devices industry

Leveraging Sales Force Competitive Intelligence for Strategic Advantage in Pharma and Medical Devices Sales force intelligence, which is technically a subset of field force intelligence, is an example of benchmarking.…

Continue ReadingSales force competitive intelligence in the pharmaceutical and medical devices industry

The Complete Dealmaking Guide to Out-licensing and Partnering for Pharma and Biotech Companies

Essential Strategies for Successful Out-Licensing and Partnering in Pharma and Biotech Industry Dealmaking in the pharmaceutical and biotech industries plays a pivotal role in fostering growth and innovation. Partnering and…

Continue ReadingThe Complete Dealmaking Guide to Out-licensing and Partnering for Pharma and Biotech Companies